# Trigger Point Injections in Anterior Cervical Surgery

> **NCT04640896** · PHASE4 · RECRUITING · sponsor: **George Washington University** · enrollment: 60 (estimated)

## Conditions studied

- Myofacial Pain
- Pain, Neck
- Pain, Back
- Cervical Fusion

## Interventions

- **DRUG:** Trigger point injection with bupivacaine
- **DRUG:** Trigger point injection with normal saline
- **DRUG:** Lidocaine skin wheal

## Key facts

- **NCT ID:** NCT04640896
- **Lead sponsor:** George Washington University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-11-05
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04640896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04640896, "Trigger Point Injections in Anterior Cervical Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04640896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*